Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MICROFLOX-250 TABLET 250 MG - HSA Drug Approval Details

Approvals/HSA/MICROFLOX-250 TABLET 250 MG

Approved

THERAPEUTIC

MICROFLOX-250 TABLET 250 MG

MICRO LABS LTD (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Sep 25, 1996
Approval ID: e305ea8601560a11
Company: MICRO LABS LTD (INDIA)
Type: Therapeutic

Approval Details

Approval Id: e305ea8601560a11
Drug Name: MICROFLOX-250 TABLET 250 MG
Product Name: MICROFLOX-250 TABLET 250 MG
Approval Number: SIN08940P
Approval Date: 1996-09-25
Registrant: NAINA MOHAMED & SONS PRIVATE LIMITED
Licence Holder: NAINA MOHAMED & SONS PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: J01MA02
Atc Item Name: ciprofloxacin
Pharma Manufacturer Name: NAINA MOHAMED & SONS PRIVATE LIMITED
Company Detail Path: /organization/naina-mohamed-and-sons-private-limited

Active Ingredients

CIPROFLOXACIN HCl EQV CIPROFLOXACIN

250 mg

CIPROFLOXACIN HCL EQV CIPROFLOXACIN

250 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Sep 25, 1996

Approval ID

e305ea8601560a11

Type

Therapeutic

Back to HSA Approvals